Update on the Scheme of Merger between Rubicon Research Ltd and KIA Healht Tech Pvt Ltd
As filed · Rubicon Research Limited has informed the Exchange about update on the Scheme of Merger between Rubicon Research Ltd and KIA Healht Tech Pvt Ltd
What happened
FactUpdate on the Scheme of Merger between Rubicon Research Ltd and KIA Healht Tech Pvt Ltd. 2026, has returned the applicaƟon regarding the fast-track approval of scheme of merger of KIA Health Tech Pvt. Further, the Scheme of merger being an internal restructuring iniƟaƟve, this order does not have any material.
Why it matters
CapitSignal interpretationA merger fixes a share-exchange ratio, which permanently sets how much of the combined company existing holders own.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Capex
ContradictedThis operational facility manufactures oral solid and oral liquid formulations and has been USFDA inspected for over a decade with 3 successful inspections.
We expect to commence manufacturing our products at the site in calendar year 2027 after completing implementation of our quality management systems.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Swap ratio and its valuation basis
- Regulatory and NCLT approvals required
- Appointed date
- We expect to commence manufacturing our products at the site in calendar year 2027 after completing implementa (management committed by FY27)
- So, on the Capex guidance, Ritika, I put it in two parts. One is that for the next couple of year, we are proj (management committed by FY27)
Evidence
- Rubicon Research Limited has informed the Exchange about update on the Scheme of Merger between Rubicon Research Ltd and KIA Healht Tech Pvt Ltd(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q2 FY25
How CapitSignal classified this
- Reasoning:
- MERGER base 74; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%